Found: 8 articles

Article Edition
E.O. Golubenko, M.I. Savelyeva, I.V. Poddubnaya, V.V. Korennaya
Possibilities of a pharmacogenetic approach to solving gynecological problems in patients taking tamoxifen: a literature review
№11 / 2023
D.V. Ivashchenko, A.Yu. Kravchenko, S.Z. Khoang, N.I. Buromskaya, P.V. Shimanov, R.V. Deitch, M.I. Nastovich, K.A. Akmalova, A.A Kachanova, L.M. Savchenko, Yu.S. Shevchenko, D.A. Sychev
Pharmacogenetic factors of haloperidol’s safety in adolescents experiencing acute psychotic episodes
№4-5 / 2023
E.O. Golubenko, M.I. Savelyeva, Zh.A. Sozaeva, I.V. Poddubnaya, V.V. Korennaya
Clinical significance of genetic polymorphism of tamoxifen metabolic enzymes and transporters in breast cancer: results of a population-based cohort study
№11-12 / 2022
O.D. Guryeva, M.I. Savelyeva, T.T. Valiev
Influence of pharmacogenetic parameters on clinical variants of methotrexate toxicity in acute lymphoblastic leukemia in children
№7 / 2022
D.V. Ivashchenko (1, 2), N.I. Buromskaya (3), P.V. Shimanov (3), R.V. Deich (3), I.V. Dorina (3), M.I. Nastovich (3), K.A. Akmalova (1), A.A. Kachanova (1), E.A. Grishina (1), L.M. Savchenko (1), Yu.S. Shevchenko (1), D.A. Sychev (1)
Pharmacogenetic predictors of the efficacy and safety of antipsychotics in adolescents with an acute psychotic episode
№11 / 2021
P.B. Shorokhova, V.L. Baranov, N.V. Vorokhobina, O.S. Shpilevaya
Genetic predictors of the pharmacological effects of dipeptidyl peptidase-4 inhibitors and sulfonylureas in patients with type 2 diabetes mellitus
№4 / 2019
E.V. Ivanova (1), E.A. Mezhevitinova (2), A.E. Donnikov (2), I.G. Nikitin (3), V.N. Prilepskaya (2)
PHARMACOGENETIC ASPECTS OF COMBINED HORMONAL CONTRACEPTION
№3 / 2016
A.A. Moiseyev
ROLE OF PHARMACOGENETICS IN INDIVIDUALIZING OF ANTICANCER CHEMOTHERAPY
№8 / 2013


Бионика Медиа